GHRP-6 10mg

For research use only — not for human or veterinary use.

Analytical Verification (COA)

Each batch of GHRP-6 supplied by Grail Formula undergoes independent third-party laboratory verification to confirm compound identity, assay content, purity and microbiological safety.

Analytical testing for this batch was performed by Liquilabs s.r.o. (Czechia) using validated chromatographic and spectrometric techniques.

Batch: GF092025034

Key analytical results include:

• Assay Content: 10.53 mg
• Identification – Retention Time: 0.998
• Identification – Spectrum: 997
• Purity: 99.8 percent
• Bacterial Endotoxins: below 0.001 EU per mg
• Total Aerobic Microbial Count: not detected
• Total Yeast and Mold Count: not detected

Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium.

These analytical procedures ensure traceability, purity verification and laboratory-grade compound consistency.

Product Overview

GHRP-6 is a synthetic growth hormone secretagogue peptide frequently studied in controlled laboratory environments investigating endocrine signalling pathways and peptide-receptor interactions.

The compound belongs to the growth hormone releasing peptide (GHRP) family, a class of synthetic peptides explored in biochemical research focused on receptor-mediated hormone signalling systems.

This preparation contains 10 mg of high purity lyophilized peptide supplied in a sealed research vial. The lyophilization process preserves peptide stability and allows researchers to reconstitute the compound for controlled in vitro experimentation.

Because of its defined peptide structure and reproducible analytical profile, GHRP-6 has become a widely referenced compound in experimental endocrine signalling and receptor interaction research models.

Compound Overview

GHRP-6, chemically known as Growth Hormone Releasing Peptide-6, is a synthetic hexapeptide developed for biochemical research involving peptide-mediated signalling pathways.

In experimental research models, the compound is investigated for its interaction with the growth hormone secretagogue receptor (GHSR), a receptor involved in endocrine signalling and hormonal regulatory systems.

Peptides within the GHRP family are frequently studied in laboratory environments examining receptor activation dynamics and peptide-receptor binding mechanisms.

These experimental models allow researchers to investigate molecular processes that regulate hormone signalling and intracellular biochemical communication.

Historical Background and Scientific Context

Scientific exploration of growth hormone regulatory peptides expanded during the late twentieth century as researchers investigated the mechanisms controlling endocrine hormone release.

During the 1980s and 1990s, several synthetic peptides were developed to interact with hormone signalling receptors in controlled laboratory studies.

This research contributed to the discovery and characterisation of the growth hormone secretagogue receptor (GHSR) and the development of peptide ligands capable of interacting with this receptor.

Within these experimental compounds, GHRP-6 became widely utilised in biochemical studies examining receptor signalling pathways and peptide-mediated endocrine regulation.

Mechanistic Focus in Research

Within experimental laboratory environments, GHRP-6 is commonly studied in relation to receptor-mediated endocrine signalling systems.

Research investigations frequently explore the compound in experimental models examining:

• Growth hormone secretagogue receptor (GHSR) interaction
• Peptide-receptor binding mechanisms
• Endocrine signalling pathway regulation
• Hormone regulatory network modelling
• Comparative secretagogue peptide research
• Peptide signalling pathway dynamics
• Intracellular regulatory signalling systems

These experimental models allow scientists to investigate molecular signalling processes that influence endocrine regulatory systems and peptide-mediated biochemical pathways.

Research Applications

In controlled research environments, GHRP-6 may be utilised in experimental models designed to explore peptide signalling and endocrine regulatory systems.

Examples of research applications include:

• Endocrine signalling pathway research
• Receptor activation studies
• Peptide-receptor interaction analysis
• Comparative secretagogue peptide evaluation
• Hormone signalling network modelling
• Cell signalling pathway research
• Controlled in vitro peptide signalling studies

Grail Formula Quality

Every Grail Formula research compound is produced under strict quality control procedures designed to support reliable laboratory experimentation.

Each batch undergoes independent analytical testing to verify:

• Compound identity
• Assay accuracy
• Purity confirmation
• Microbial safety
• Endotoxin levels
• Heavy metal screening
• Full batch traceability

All testing is performed by independent laboratories to ensure transparent verification and reproducible research material.

Research Use Limitation

• Used solely for in vitro experiments
• Not permitted for clinical trials involving humans
• Not permitted for human or veterinary administration
• Not permitted for investigational human use

• Verified and analysed with Liquilabs s.r.o. Czechia
• 99.8 percent purity with validated assay content
• No detectable heavy metals or microbial contamination
• Endotoxin below 0.001 EU per mg
• Batch GF092025034 – Published October 2025
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.